Lataa...
The LncRNA HOTAIRM1 Promotes Tamoxifen Resistance by Mediating HOXA1 Expression in ER+ Breast Cancer Cells
Breast cancer is one of the most commonly diagnosed cancers in women worldwide. Approximately 40% of patients with breast cancer acquire endocrine resistance following therapy with tamoxifen. Many explanations for the development of endocrine resistance have been put forward, one of them being the d...
Tallennettuna:
| Julkaisussa: | J Cancer |
|---|---|
| Päätekijät: | , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Ivyspring International Publisher
2020
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7150441/ https://ncbi.nlm.nih.gov/pubmed/32284737 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/jca.38728 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|